Skip to main content
logo
Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
13.95
-2.60 (-15.71%)
At close: Oct 13, 2026, 4:00 PM EDT
13.96
+0.01 (0.07%)
After-hours: Oct 13, 2026, 5:32 PM EDT

Syndax Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-220.77-285.42-318.76-209.36-149.3424.93
Depreciation & Amortization
0.020.010.010.010.030.04
Other Amortization
0.420.230.03---
Loss (Gain) From Sale of Investments
-5.51-10.75-13.47-14.8-3.380.64
Stock-Based Compensation
49.447.543.0330.9516.0213.32
Provision & Write-off of Bad Debts
3.673.67----
Other Operating Activities
1.531.110.990.741.34-0.2
Change in Accounts Receivable
-25.61-30.39-7.6---
Change in Inventory
-15.2-32.09-0.37---
Change in Accounts Payable
-12.484.951.675.61-1.322.16
Change in Unearned Revenue
------13.13
Change in Other Net Operating Assets
3.9-21.7919.5726.252.981.38
Operating Cash Flow
-220.64-322.98-274.9-160.6-133.6829.13
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.23-0.19----0.13
Sale of Property, Plant & Equipment
----0.23-
Investment in Securities
175.71290.22-219.78117.61-186.41-40.74
Investing Cash Flow
175.48290.04-219.78117.61-186.19-40.87

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
-----21-
Net Debt Issued (Repaid)
243.85----21-
Issuance of Common Stock
29.0413.689.72278.18193.25117.89
Other Financing Activities
--343.65-14.04-0.58
Financing Cash Flow
272.8813.68353.37264.13172.25118.46

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
227.73-19.27-141.31221.14-147.61106.72

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-220.87-323.17-274.9-160.6-133.6829
Free Cash Flow Growth
------
Free Cash Flow Margin
-87.56%-187.50%-1160.91%--20.76%
Free Cash Flow Per Share
-2.52-3.73-3.21-2.28-2.200.54
Levered Free Cash Flow
-150.08-209.8-155.26-82.37-76.2732.03
Unlevered Free Cash Flow
-124-188.92-152.21-82.24-74.3133.22

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
13.45---2.062
Change in Working Capital
-49.4-79.3213.2731.861.66-9.6
SEC Filings: 10-K · 10-Q